DCGI

The company will now be initiating Phase III clinical trial in around 30,000 volunteers

DCGI’s decision comes after the Subject Expert Committee of CDSCO met on January 1-2, 2021 and recommended the grant of permission…

The expert panel deliberated on Bharat Biotech’s EUA application after it submitted additional data, facts and analysis after…

The SEC is also looking at the EUA applications of Pfizer and Bharat Biotech

The company made this statement after UK's approval of the Oxford-AstraZeneca COVID-19 vaccine

The FDC will be marketed under two brand names, Remo V and Remozen V, priced at Rs 14 per tab and Rs 28 per day cost of therapy

It is indicated as an add-on maintenance treatment for severe asthma with an eosinophilic phenotype in adult patients

Inaugurated by DV Sadananda Gowda, the theme for the virtual two-day Summit is ‘India’s Healthcare Transformational Journey’

Serum Institute has currently applied with the DCGI for emergency authorization of Covishield in the country

It is an indigenous mRNA vaccine candidate supported with seed grant under the Ind-CEPI mission of Department of Biotechnology of…